Accessibility Menu
Medartis Ag logo

Medartis Ag(OTC) MDRSF

Market Cap$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+141%
5 Year+95%
1 Year+13%
1 Month+0%
$115.00
+0.00%
+0.00Today
Medartis Ag last closing stock price
MetricPriceDate
Last closeUSD 115.002026-08-18
Medartis Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 115.002026-07-13
1 month+0%USD 115.002026-07-13
3 month+0%USD 115.002026-04-24
Year to date+15%USD 100.002025-10-27
1 year+12.73%USD 102.012025-07-17
3 year+47.51%USD 77.962023-08-03
5 year+94.92%USD 59.002021-05-18
Since inception+140.84%USD 47.752020-01-17

Medartis Ag Financials at a Glance

Market Cap

$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 542.56M

Net Income (TTM)

CHF 14.41M

EPS (TTM)

$1.51

P/E Ratio

76.21

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Price

$115.00

Volume

200

Open

$115.00

Previous Close

$115.00

Daily Range

$115.00 - $115.00

52-Week Range

$100.00 - $115.00

Estimated Earnings Date

Mar 2, 2027

MDRSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medartis Ag

Medartis Holding AG is a Switzerland-based medical technology firm specializing in advanced implant solutions for surgical repair and stabilization of bone fractures. Founded in 1997 and headquartered in Basel, the company operates under the APTUS and MODUS brands, providing a comprehensive range of osteosynthesis instruments for various anatomical applications.

Products and Services
  • Advanced implant solutions for bone fractures
  • Osteosynthesis instruments for upper and lower limb surgeries
  • Specialized tools for cranio-maxillofacial procedures
Growth Outlook
  • Revenue of CHF 159.93 million in Q2 2026, a significant increase
  • Gross profit margin improved to 81.7% in Q2 2026
  • Strong demand for innovative surgical solutions driving market expansion
Financial Highlights
  • Net income of CHF 5.09 million in Q2 2026
  • Operating income margin of 8.1% in Q2 2026
  • Current ratio of 3.36, indicating strong liquidity position
Medartis Holding AG has established itself as a key player in the medical devices industry, focusing on innovative solutions that cater to the needs of surgeons and healthcare providers. The company's recent financial performance reflects a robust growth trajectory, with a notable increase in revenue and gross profit margins. The strong liquidity position, as indicated by the current ratio, further supports the company's ability to invest in research and development, ensuring continued innovation in its product offerings. With a commitment to enhancing surgical outcomes, Medartis is well-positioned to capitalize on the growing demand for advanced medical technologies in the global market.
AI Generated • Aug 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,337

CEO

Matthias Schupp

Website

www.medartis.com

Headquarters

Basel, BS 4057, CH

MDRSF Financials

Key Financial Metrics (TTM)

Gross Margin

77.48%

Operating Margin

1.61%

Net Income Margin

4.86%

Return on Equity

5.35%

Return on Capital

0.45%

Return on Assets

2.45%

Earnings Yield

1.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.45M

Volume

200

Avg. Volume

4.688

Financials (TTM)

Gross Profit

CHF 424.17M

Operating Income

CHF 26.29M

EBITDA

CHF 68.31M

Operating Cash Flow

CHF 60.85M

Capital Expenditure

-CHF 40.13M

Free Cash Flow

CHF 20.72M

Cash & ST Invst.

CHF 25.66M

Total Debt

CHF 206.10M

Medartis Ag Performance Analysis

Medartis Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 191,426,1299.5%
20232023-12-31CHF 235,915,63723.2%
20242024-12-31CHF 255,296,1058.2%
20252025-12-31CHF 324,216,08827.0%
Medartis Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-311.6%
Q22025-06-308.6%
Q42025-12-3118.9%
Q22026-06-309.3%
Medartis Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF -0.51N/A
20232023-12-31CHF 0.06N/A
20242024-12-31CHF 0.32473.5%
20252025-12-31CHF 0.81150.1%
Medartis Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-63.2%
Q22025-06-30-271.4%
Q42025-12-31758.3%
Q22026-06-30-48.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 159.93M

+43.4%

Gross Profit

CHF 130.66M

+45.9%

Gross Margin

81.70%

N/A

Market Cap

$1.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.07M

N/A

Employees

1,337

N/A

Net Income

CHF 5.09M

+98.6%

EBITDA

CHF 28.09M

+80.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 25.66M

-79.8%

Total Debt

CHF 206.10M

+70.4%

Accounts Receivable

CHF 74.51M

+50.9%

Inventory

CHF 101.89M

+30.4%

Long Term Debt

CHF 195.57M

+71.9%

Short Term Debt

CHF 10.53M

+46.1%

Return on Assets

2.45%

N/A

Return on Invested Capital

0.90%

N/A

Free Cash Flow

-CHF 10.23M

-345.2%

Operating Cash Flow

CHF 5.27M

-43.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BITGFBiotage AB (publ)
$15.01+0.00%
DGWPFDrägerwerk AG & Co. KGaA
$93.00+0.00%
SSIISS Innovations International, Inc.
$3.46-0.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.40-0.19%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.74+0.08%
NVDANvidia
$219.73+0.01%
BITOProShares Trust - ProShares Bitcoin ETF
$10.60+0.01%

Questions About MDRSF

What is the current price of Medartis Ag?

Medartis Ag is trading at $115.00 per share.

What is the 52-week range for Medartis Ag?

Over the past 52 weeks, Medartis Ag has traded between $100.00 and $115.00.

How much debt does Medartis Ag have?

As of the most recent reporting period, Medartis Ag reported total debt of CHF 199.58M.

How much cash does Medartis Ag have on hand?

Medartis Ag reported CHF 41.61M in cash and cash equivalents in its most recent financial results.

What is Medartis Ag’s dividend yield?

Medartis Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services